Pharmaceutical PV DIV - FSB
Ended Awarded
- Contract number
- SPE2DU26FB784
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $56,048
Award facts
- Contract value 100% obligated
- $56,048.16 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $56,048.16 to AmerisourceBergen Drug Corp for pharmaceutical products and services under a firm fixed-price contract. The delivery order, issued on November 18, 2025, with an ultimate completion date of the same day, represents a non-competitive set-aside award to the Conshohocken, Pennsylvania-based pharmaceutical distributor. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026 that enables the contractor to supply a broad range of pharmaceutical products, medications, vaccines, and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through its extensive portfolio of brand-name and generic medications, specialty pharmaceuticals, and medical devices across multiple therapeutic domains. The parent IDC with DLA positions the company as a prime vendor capable of fulfilling diverse pharmaceutical requirements for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The DLA is planning to establish the Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards anticipated, further demonstrating the strategic importance of pharmaceutical supply chain management within the federal procurement framework.
Quick answers
Who was awarded contract SPE2DU26FB784?
SPE2DU26FB784 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 18, 2025.
How much is contract SPE2DU26FB784 worth?
The government has obligated $56,048 on SPE2DU26FB784.
Is contract SPE2DU26FB784 an order under another contract?
Yes. SPE2DU26FB784 is a delivery order under SPE2DU25D4211, an indefinite delivery contract.
Was contract SPE2DU26FB784 competed?
The extent of competition for SPE2DU26FB784 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award